Psilocybin, a substance found in so-called “hallucinogenic mushrooms,” produces visual and auditory hallucinations and profound alterations in consciousness after a few hours of ingestion. In 2016, researchers at Johns Hopkins Medicine were the first to discover that psilocybin treatment combined with psychological support reduced existential anxiety and depression in people diagnosed with life-threatening cancer.
